{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:08:16Z","timestamp":1778454496786,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781071650363","type":"print"},{"value":"9781071650370","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5037-0_13","type":"book-chapter","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:11:13Z","timestamp":1778451073000},"page":"175-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluorescent-Based Analysis of T Cells and T-Cell-Dependent Bispecific Antibody in a Brain Tumor Mouse Model"],"prefix":"10.1007","author":[{"given":"Yuri","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"1","key":"13_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. CA Cancer J Clin 74(1):12\u201349","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"13_CR2","first-page":"e72805","volume":"16","author":"R Manake","year":"2024","unstructured":"Manake R, Phillips V, Gangi A, Ravikumar J (2024) Trends in the incidence of brain cancer: an observational study. Cureus 16(10):e72805","journal-title":"Cureus"},{"key":"13_CR3","unstructured":"\u8fd1\u85e4\u8061\u82f1 (2024) \u8133\u816b\u760d\u306e\u6700\u65b0\u6cbb\u7642. \u795e\u7d4c\u6cbb\u7642 41(4):479\u2013484"},{"issue":"4","key":"13_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrclinonc.2014.25","volume":"11","author":"TK Owonikoko","year":"2014","unstructured":"Owonikoko TK, Arbiser J, Zelnak A, Shu H-KG, Shim H, Robin AM et al (2014) Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol 11(4):203\u2013222","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"13_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrclinonc.2011.58","volume":"8","author":"AF Eichler","year":"2011","unstructured":"Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 8(6):344\u2013356","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"13_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/156800912799277511","volume":"12","author":"D Fortin","year":"2012","unstructured":"Fortin D (2012) The blood-brain barrier: its influence in the treatment of brain tumors metastases. Curr Cancer Drug Targets 12(3):247\u2013259","journal-title":"Curr Cancer Drug Targets"},{"issue":"7560","key":"13_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337\u2013341","journal-title":"Nature"},{"issue":"6301","key":"13_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1126\/science.aag2638","volume":"353","author":"J Kipnis","year":"2016","unstructured":"Kipnis J (2016) Multifaceted interactions between adaptive immunity and the central nervous system. Science 353(6301):766\u2013771","journal-title":"Science"},{"issue":"4","key":"13_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s11481-013-9470-8","volume":"8","author":"JD Laman","year":"2013","unstructured":"Laman JD, Weller RO (2013) Drainage of cells and soluble antigen from the CNS to regional lymph nodes. J Neuroimmune Pharmacol 8(4):840\u2013856","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"13_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","volume":"20","author":"T McGranahan","year":"2019","unstructured":"McGranahan T, Therkelsen KE, Ahmad S, Nagpal S (2019) Current state of immunotherapy for treatment of glioblastoma. Curr Treat Options Oncol 20(3):24","journal-title":"Curr Treat Options Oncol"},{"issue":"10","key":"13_CR11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1158\/1535-7163.MCT-22-0201","volume":"21","author":"R Iurlaro","year":"2022","unstructured":"Iurlaro R, Waldhauer I, Planas-Rigol E, Bonfill-Teixidor E, Arias A, Nicolini V et al (2022) A novel EGFRvIII T-cell bispecific antibody for the treatment of glioblastoma. Mol Cancer Ther 21(10):1499\u20131509","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"13_CR12","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1158\/1078-0432.CCR-15-1696","volume":"22","author":"M Bacac","year":"2016","unstructured":"Bacac M, Fauti T, Sam J, Colombetti S, Weinzierl T, Ouaret D et al (2016) A novel carcinoembryonic antigen T-cell bispecific antibody (CEA TCB) for the treatment of solid tumors. Clin Cancer Res 22(13):3286\u20133297","journal-title":"Clin Cancer Res"},{"issue":"6012","key":"13_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/314628a0","volume":"314","author":"UD Staerz","year":"1985","unstructured":"Staerz UD, Kanagawa O, Bevan MJ (1985) Hybrid antibodies can target sites for attack by T cells. Nature 314(6012):628\u2013631. https:\/\/doi.org\/10.1038\/314628a0","journal-title":"Nature"},{"issue":"5","key":"13_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1158\/2326-6066.CIR-19-0518","volume":"8","author":"D Chiu","year":"2020","unstructured":"Chiu D, Tavar\u00e9 R, Haber L, Aina OH, Vazzana K, Ram P et al (2020) A PSMA-targeting CD3 bispecific antibody induces antitumor responses that are enhanced by 4-1BB costimulation. Cancer Immunol Res 8(5):596\u2013608","journal-title":"Cancer Immunol Res"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"575737","DOI":"10.3389\/fonc.2020.575737","volume":"10","author":"J Sam","year":"2020","unstructured":"Sam J, Colombetti S, Fauti T, Roller A, Biehl M, Fahrni L et al (2020) Combination of T-cell bispecific antibodies with PD-L1 checkpoint inhibition elicits superior anti-tumor activity. Front Oncol 10:575737","journal-title":"Front Oncol"},{"issue":"24","key":"13_CR16","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1158\/0008-5472.CAN-12-2027","volume":"72","author":"K Franciszkiewicz","year":"2012","unstructured":"Franciszkiewicz K, Boissonnas A, Boutet M, Combadi\u00e8re C, Mami-Chouaib F (2012) Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response. Cancer Res 72(24):6325\u20136332","journal-title":"Cancer Res"},{"key":"13_CR17","doi-asserted-by":"crossref","unstructured":"Uppaluri R, Sheehan KCF, Wang L, Bui JD, Brotman JJ, Lu B (2008) Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation. 86(1):137\u2013147","DOI":"10.1097\/TP.0b013e31817b8e4b"},{"issue":"4","key":"13_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/eji.1830250432","volume":"25","author":"S Isaaz","year":"1995","unstructured":"Isaaz S, Baetz K, Olsen K, Podack E, Griffiths GM (1995) Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur J Immunol 25(4):1071\u20131079","journal-title":"Eur J Immunol"},{"issue":"1","key":"13_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00262-020-02667-9","volume":"70","author":"D Kamakura","year":"2021","unstructured":"Kamakura D, Asano R, Kawai H, Yasunaga M (2021) Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation. Cancer Immunol Immunother 70(1):177\u2013188","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"13_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1158\/2326-6066.CIR-13-0049","volume":"1","author":"BD Choi","year":"2013","unstructured":"Choi BD, Gedeon PC, Herndon 2nd JE, Archer GE, Reap EA, Sanchez-Perez L et al (2013) Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody. Cancer Immunol Res 1(3):163","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"13_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","volume":"24","author":"P Chongsathidkiet","year":"2018","unstructured":"Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH et al (2018) Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat Med 24(9):1459\u20131468","journal-title":"Nat Med"},{"issue":"4","key":"13_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H et al (2018) The immune landscape of cancer. Immunity 48(4):812\u2013830","journal-title":"Immunity"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3389\/fimmu.2017.01181","volume":"8","author":"R Razpotnik","year":"2017","unstructured":"Razpotnik R, Novak N, \u010curin \u0160erbec V, Rajcevic U (2017) Targeting malignant brain tumors with antibodies. Front Immunol 8:1181","journal-title":"Front Immunol"},{"issue":"1","key":"13_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12987-021-00257-0","volume":"18","author":"R Faresj\u00f6","year":"2021","unstructured":"Faresj\u00f6 R, Bonvicini G, Fang XT, Aguilar X, Sehlin D, Syv\u00e4nen S (2021) Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size. Fluids Barriers CNS 18(1):26","journal-title":"Fluids Barriers CNS"}],"container-title":["Methods in Molecular Biology","Bispecific Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5037-0_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:11:14Z","timestamp":1778451074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5037-0_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650363","9781071650370"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5037-0_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}